AMERICAN SHARED HOSPITAL SERVICES Cost Method Investments, Fair Value Disclosure
AMERICAN SHARED HOSPITAL SERVICES (AMS) had Cost Method Investments, Fair Value Disclosure of $0 as of 2017-12-31, per its 10-K filed 2018-03-28.
Discontinued › Notes › Investments
us-gaap:CostMethodInvestmentsFairValueDisclosure · last filed 2018-03-28
- 2017-12-31: Cost Method Investments, Fair Value Disclosure $0.00.
- 2017-09-30: Cost Method Investments, Fair Value Disclosure $579.00K.
- 2017-06-30: Cost Method Investments, Fair Value Disclosure $579.00K.
- 2017-03-31: Cost Method Investments, Fair Value Disclosure $579.00.
| Period end | Cost Method Investments, Fair Value Disclosure |
|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-03-28 |
| 2017-09-30 | $579.00K 10-Q · filed 2017-11-13 |
| 2017-06-30 | $579.00K 10-Q · filed 2017-08-10 |
| 2017-03-31 | $579.00 10-Q · filed 2017-05-15 |
| 2016-12-31 | $579.00K 10-K · filed 2018-03-28 |
| 2016-09-30 | $579.00K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $579.00K 10-Q · filed 2016-08-11 |
| 2016-03-31 | $579.00K 10-Q · filed 2016-05-12 |
| 2015-12-31 | $579.00K 10-K · filed 2017-03-27 |
| 2015-09-30 | $600.00K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $600.00K 10-Q · filed 2015-08-19 |
| 2015-03-31 | $330.00K 10-Q · filed 2015-05-14 |
| 2014-12-31 | $330.00K 10-K · filed 2016-03-30 |
| 2014-09-30 | $300.00K 10-Q · filed 2014-11-14 |
| 2014-06-30 | $300.00K 10-Q · filed 2014-08-15 |
| 2014-03-31 | $300.00K 10-Q · filed 2014-05-15 |
| 2013-12-31 | $300.00K 10-K · filed 2015-04-01 |
| 2012-12-31 | $1.30M 10-K · filed 2014-03-31 |
| 2012-09-30 | $1.38M 10-Q · filed 2012-11-14 |
| 2012-06-30 | $1.38M 10-Q/A · filed 2012-09-07 |
| 2011-12-31 | $1.38M 10-Q · filed 2012-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |